# DESCRIPTION

## ACKNOWLEDGEMENT OF GOVERNMENT SUPPORT

- acknowledge government funding

## BACKGROUND OF THE INVENTION

### 1. Field of the Invention

- define field of invention

### 2. Description of the Related Art

- describe limitations of prior art

## SUMMARY OF THE INVENTION

- introduce recombinant progenitor cell
- describe method of producing functional effector cell
- outline method of inhibiting viral infection

## DETAILED DESCRIPTION OF THE INVENTION

- introduce HIV-targeted T-cells using CARs
- describe genetic modification of HSCs with CARs
- summarize advantages of CARs over natural TCRs
- outline treatment methods and benefits

### Preliminary Studies

- demonstrate HIV-TCR construct in humanized mice
- introduce CD4ζ CAR construct and test for HIV killing
- show CD4ζ CAR construct is not HLA-restricted
- test CARs in CD4+ T-cells as HIV-1-specific helper cells
- determine CD8+ T-cells susceptibility to HIV infection
- combine CD4ζ CAR with anti-HIV reagents for protection
- test Triple CAR construct in humanized mice
- present preliminary studies
- describe procedures
- outline antibody and flow cytometry methods
- detail lentiviral vector production
- quantify TCR rearrangement excision circles
- define novel CAR production
- describe CAR construct modifications
- outline generation of second generation CAR constructs

## ADDITIONAL EXAMPLES

### Selection of Stem Cell Type

- introduce CD34+ hematopoietic stem cells
- describe TSCM cells and their properties
- outline methods for TSCM cell derivation and expansion

### Anti-HIV Activity and Generation of Functional Immune Responses

- assess antiviral efficacy and immune function in BLT mice

### Effect of CARs on Viral Reservoir

- evaluate ability of CAR-expressing cells to kill reservoir cells

### Clonal Tracking of Repopulating Cells in BLT Mice

- track repopulating cells by monitoring vector integration sites

### Bioinformatics Analysis

- analyze VIS sequence data using bioinformatics tools

### In Vivo Activity in the NHP Model

- assess engraftment of CAR-transduced HSCs in NHP model
- evaluate ability of CAR-expressing cells to decrease plasma viral load

### Therapeutics

- genetically engineer human cellular immune response against HIV
- outline desired dose, route, and regimen for therapy

## LITERATURE

- list prior art references
- incorporate references by reference
- disclaim anticipation and obviousness

